Copeptin levels in patients with vasovagal syncope

Area of Science:

• Cardiology
• Neuroscience

Background:

• Vasovagal syncope (VVS) involves multiple mechanisms.
• Copeptin, a marker for arginine-vasopressin, increases after VVS episodes.

Purpose of the Study:

• To examine copeptin level dynamics in VVS patients.
• To categorize VVS by vasoconstriction during orthostasis.
• To compare VVS patients with healthy controls.

Main Methods:

• Studied four groups: adequate vasoconstriction (A), impaired vasoconstriction (B), VVS history with negative tilt (C), and healthy controls (D).
• Assessed limb vasoconstriction using plethysmography.
• Measured plasma copeptin before and 5 minutes after tilt test.

Main Results:

• Baseline copeptin was similar across all groups.
• Copeptin significantly increased during tilt in all VVS patient groups (A, B, C), including those with negative tests.
• Group B (impaired vasoconstriction) showed a greater copeptin increase post-tilt compared to other groups.

Conclusions:

• Copeptin elevation occurs after tilt testing in VVS patients with both positive and negative responses.
• Increased copeptin following orthostasis may be a diagnostic marker for VVS.
• Copeptin dynamics provide insights into VVS pathophysiology.